Korean Stock
ISSU
NGeneBio
★★★★
NGeneBio Announces 22.4 Billion Won Rights Offering, Diluting Existing Shares by 80.01%
 05/19/2026, 04:58 PM
MATR
NGeneBio
★
Rights Offering at 0.8 New Shares per Existing Share After 3:1 Reverse Stock Split
 05/16/2026, 07:51 PM
EXCH
NGeneBio
★★
Extraordinary General Meeting to Approve Capital Reduction for Deficit Coverage
 05/16/2026, 07:51 PM
MATR
NGeneBio
★
Capital Reduction to Cover Deficits, No Specific Ratio Disclosed
 05/16/2026, 07:51 PM
EXCH
NGeneBio
★★★★★
Trading Suspension Due to Capital Reduction
 05/16/2026, 07:51 PM
EXCH
NGeneBio
★
Record Date Set for Extraordinary General Meeting (2026-05-12)
 05/16/2026, 07:51 PM
PERI
NGeneBio
★
NGeneBio Q1 2026 Revenue Surges (Merger Effect) but Losses Continue; Decides Reverse Stock Split and Rights Offering to Improve Financial Structure
 05/15/2026, 04:09 PM